Afatinib and osimertinib in lung adenocarcinoma harbored EGFR T751_I759delinsS mutation: A case report-Reference-Cited by-同舟云学术

Afatinib and osimertinib in lung adenocarcinoma harbored EGFR T751_I759delinsS mutation: A case report

Published:2021-11-02 Issue:24 Volume:12 Page:3429-3432
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thoracic Cancer

Author:

Fang Yueh‐Fu¹²^ORCID,Liu Ping‐Chi³

Affiliation:

1. Department of Thoracic Medicine, Chang Gung Foundation Chang Gung Memorial Hospital Taoyuan Taiwan

2. College of Medicine Chang Gung University Taoyuan Taiwan

3. Divison of Pulmonary, Critical Care, and Sleep Medicine Chang Gung Memorial Hospital Keelung Taiwan

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.14215

Reference14 articles.

1. Complex mutation patterns of epidermal growth factor receptor gene associated with variable responses to gefitinib treatment in patients with non-small cell lung cancer

2. Comparison of three methods for detecting epidermal growth factor receptor mutations in plasma DNA samples of Chinese patients with advanced non‐small cell lung cancer;Qin L;Chin Med J (Engl),2011

3. Osimertinib for Patients With Non–Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Multicenter, Open-Label, Phase II Trial (KCSG-LU15-09)

4. Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: a combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6

5. Uncommon EGFR mutations in lung adenocarcinoma: features and response to tyrosine kinase inhibitors

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Osimertinib treatment response in a patient with lung adenocarcinoma harboring two rare EGFR mutations: A case report;Oncology Letters;2024-08-16

2. Afatinib for the Treatment of NSCLC with Uncommon EGFR Mutations: A Narrative Review;Current Oncology;2023-05-28

3. EGFR T751_I759delinsN Mutation in Exon19 Detected by NGS but Not by Real-Time PCR in a Heavily-Treated Patient with NSCLC;International Journal of Molecular Sciences;2022-11-03

4. Case Report: Durable partial response to icotinib plus crizotinib in a lung adenocarcinoma patient with double uncommon EGFR G719D/L861Q mutations and an acquired novel CUX1-MET fusion;Frontiers in Oncology;2022-07-26

5. Afatinib/durvalumab;Reactions Weekly;2022-05